Kimia Biosciences gets nod to manufacture, market Azelnidipine API

29 Apr 2020 Evaluate

Kimia Biosciences has been granted permission to manufacturing and marketing of new active pharmaceutical ingredient Azelnidipine drug by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare.

Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Kimia Biosciences Share Price

30.21 0.00 (0.00%)
19-Dec-2025 11:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1746.05
Dr. Reddys Lab 1273.70
Cipla 1505.60
Zydus Lifesciences 913.05
Lupin 2117.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×